Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy
MT NewswiresFeb 13 16:41
Takeda Pharmaceutical Company (TAK) Receives a Hold From J.P. Morgan
TipRanksNov 28, 2023 20:16
Hutchmed Upgraded at Deutsche Bank; Cancer Drug Approval Cited
Seeking AlphaNov 24, 2023 21:54
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy
MT NewswiresOct 3, 2023 17:49
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy
MT NewswiresSep 22, 2023 19:30
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy
MT NewswiresMay 31, 2023 17:59
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating
MT NewswiresMay 16, 2023 21:16
TD Cowen Maintains Outperform on Takeda Pharmaceutical, Lowers Price Target to $20
BenzingaMay 16, 2023 19:19
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating
MT NewswiresApr 4, 2023 20:27
TD Cowen Maintains Outperform on Takeda Pharmaceutical, Raises Price Target to $30
BenzingaApr 4, 2023 19:30
B of A Securities Upgrades Takeda Pharmaceutical to Buy, Announces $20 Price Target
BenzingaMar 16, 2023 18:54
Analysts' Opinions Are Mixed on These Healthcare Stocks: Intercept Pharma (ICPT) and Takeda Pharmaceutical Company (TAK)
TipRanksMar 13, 2023 20:17
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy
MT NewswiresMar 6, 2023 18:14
J.P. Morgan Sticks to Their Hold Rating for Takeda Pharmaceutical Company (TAK)
TipRanksDec 16, 2022 20:10
No Data
No Data